Public needs help to be healthy, Kings Fund
June 13, 2008The King's Fund has called for greater effort to be made by government to help people improve their health. The …
GSK’s Tyverb granted conditional licence in EU
June 13, 2008Sales and Marketing
European regulators have given GlaxoSmithKline's Tyverb conditional approval, clearing it for launch but asking for more clinical data. Tyverb (lapatinib) …
Daiichi Sankyo acquires Ranbaxy
June 13, 2008Sales and Marketing
Japanese company Daiichi Sankyo is set to take over Ranbaxy, the largest manufacturer of generic drugs in India. Ranbaxy will …
Doctors ‘scaremongering’ over polyclinics
June 10, 2008The health secretary has hit back in the fight over polyclinics saying the BMA is not being honest with its …
Latest news from Datamonitor
June 10, 2008Sales and Marketing
Pharmacovigilance solutions: essential for the future of healthcareAlthough many newer pharmacovigilance solutions are still in the nascent stages, and despite …
Think tank questions polyclinic plans
June 6, 2008A government strategy to transform primary care in England has been dealt a blow by a respected think tank, which …
Erbitux set for first line treatment of colorectal cancer
June 5, 2008Sales and Marketing Cancer, Merck Serono
Merck Serono's Erbitux looks set for approval in Europe as a first-line colon cancer treatment. Approved four years ago as …
Data boost for Avastin
June 5, 2008Sales and Marketing
A new study has confirmed that Roche's Avastin significantly extends time without disease progression for women with metastatic breast cancer. …
Latest news from Datamonitor
June 3, 2008Sales and Marketing
Drug distribution restricted as manufacturers attempt to guard supply chain Ideally, drug supply should be a simple and transparent chain …
Sanofi fights to block generic Plavix in Germany
June 3, 2008Sales and Marketing
Sanofi-Aventis is taking legal action to prevent the launch of a generic competitor to its blockbuster Plavix in Germany. At …
Close to home: the UK’s regional NHS influencers
June 3, 2008Sales and Marketing NICE, UK, healthcare, influencers, regional
With so much attention directed at NICE since the parliamentary health select committee reported on the organisation in January, it …
Roche increases stake in Chugai
May 30, 2008Sales and Marketing
Roche is strengthening its hold over Japanese drug firm Chugai, increasing its stake in the company from 50.1% to 59.9%. …
A million more patients to get statins
May 30, 2008Sales and Marketing
Statin prescribing could be set to increase massively once again following new NICE guidance on cholesterol-lowering treatments. An extra 1.5 …
Schering-Plough to exploit new NICE transparency
May 30, 2008Sales and Marketing
NICE has recommended two anti-TNF treatments for ankylosing spondylitis, the painful and progressive rheumatic disease, but has excluded a third …
BMA rails against polyclinics
May 30, 2008Doctors have come together to attack plans to introduce polyclinics to London, claiming the reforms are not proven to improve …
Merck’s odanacatib shows promise in cancer
May 30, 2008Research and Development, Sales and Marketing
Merck's odanacatib (MK-0822) has shown promising results in phase II trials in treating breast cancer which has spread to bones. …
Groundbreaking pharma-NHS collaboration launched in Nottingham
May 30, 2008ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working
A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …
7 principles in marketing to the new NHS
May 28, 2008Sales and Marketing NHS, healthcare, marketing
Developing a successful market access strategy has become the Holy Grail for brand teams across the UK pharmaceutical industry.
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
